Former Congressman Dr. Phil Gingrey provides public policy and government relations counsel to clients on a variety of issues. Here at Phil on the Hill, Phil draws upon his long career in public service to provide perspective and context on policy topics such as health care, the federal budget, annual appropriations, regulatory reform, and life sciences.
Congress Needs to Double-Down on Recent Progress
Friday, July 20, 2018
Phil discusses recent progress on health care bills and the need to keep momentum going to pass more lifesaving legislation.
Anti-Kickback Statutes Need to Adapt to Value-Based Care
Monday, July 16, 2018
Phil discusses the need to reform anti-kickback and self-referral laws, which can hamper the ability of doctors and health systems to provide the best care under modern value-based care models.
Trump’s Plan on Drug Pricing
Wednesday, July 11, 2018
Phil shares his insights on the Trump Administration’s plans to get prescription drug prices under control.
Don't be penny wise, pound foolish with 340B drug pricing program
Monday, July 09, 2018
Phil discusses how cuts to the 340B drug pricing program would significantly affect the health of low-income patients and ultimately taxpayers.
1
To follow Phil on Twitter, visit @DrPhilGingrey.
Recent Posts
- August: Good Time to Question Your Congressman
- Why Kavanaugh Nomination Won’t (For Long) Be a Black Hole for Everything Else
- Congress Needs to Double-Down on Recent Progress
- Anti-Kickback Statutes Need to Adapt to Value-Based Care
- Trump’s Plan on Drug Pricing
- Don't be penny wise, pound foolish with 340B drug pricing program
- Three Ways to Boost Physician and Heath Professional Legislators in Congress
- Interoperable Health Records and 21st Century Cures
- Let’s Admit a Few Things About Readmission
- Long-Term Thinking About Budgets and Preventative Health
